Clinical Trial

Impact of Smart Connected Insulin Pens on Quality of Life in Dependent Patients with Diabetes Using Continuous Glucose Measurement

Study acronym: BESTYLCO
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated March 14, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
Insulin-treated diabetes in dependent or institutionalized patients is often poorly balanced and continuous glucose measurement is underused. The purpose of this tudy is to know how smart connected insulin pens and continuous glucose measurement can improve insulin therapy practice in dependent and/or institutionalized patients?
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2023-12-20; most recent amendment 2025-03-12.
Status change: Not Yet Recruiting → Recruiting 2024-04-05
Trial Details
NCT Number NCT06192940
Lead Sponsor Centre Hospitalier Sud Francilien
Conditions Diabetes
Enrollment 30 participants
Start Date 2024-03-28
Primary Completion 2025-12-31 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-03-14